Table 1– Determinants of change in bronchial reactivity slope in participants with complete covariate data and no asthma medication#
CovariateChange in bronchial reactivity slope % (95% CI)p-value
Female sex-3.9 (-21.116.9)0.689
Age
 Centered at 40 yrs per yr0.9 (0.41.5)0.001
 Centered at 40 yrs2 per yr20.0 (0.00.1)0.024
 Centered at 40 yrs only linear term per yr1.5 (0.72.3)<0.001
ETS exposure
 Never-smoker-1.0 (-16.016.7)0.908
 Ever-smoker10.7 (-10.136.3)0.340
Positive Phadiatop test at baseline-6.3 (-15.84.2)0.230
BMI
 Centered at 25 kg·m−2 per unit-0.1 (-1.61.4)0.847
 Change between surveys per unit2.7 (0.35.2)0.030
Smoking
 Being a smoker at baseline21.2 (7.536.7)0.002
 Being an ex-smoker at baseline-5.1 (-18.210.1)0.487
 Pack-yrs in ever-smokers+ per 5 yrs2.1 (0.04.2)0.048
 Pack-yrs in smokers+ per 5 yrs3.6 (1.65.6)<0.001
 Pack-yrs in ex-smokers+ per 5 yrs-2.4 (-6.51.9)0.267
  • Bold indicates statistically significant p-values. ETS: environmental tobacco smoke; BMI: body mass index. #: n = 3,005. : from the baseline value; bronchial reactivity slope is defined as percentage change in forced expiratory volume in 1 s per micromole of methacholine; estimates are expressed in percentage change from baseline slope and adjusted for all other covariates in the table plus concurrent colds at both examinations, seasonal terms, baseline lung function (forced expiratory volume in 1 s, forced vital capacity (FVC) and forced expiratory flow at 25–75% of FVC) and study area. +: pack-yrs in ever-smokers and in smokers/ex-smokers were entered into the model instead of the smoking variables.